Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis

BACKGROUND: JAK inhibitors are a relatively new class of medications that may be useful in the treatment of moderate-to-severe psoriasis and psoriatic arthritis (PsA). The objective of this study was to determine the efficacy of several JAK inhibitors in treating psoriasis and PsA and examine safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarabia, Samantha, Ranjith, Brandan, Koppikar, Sahil, Wijeratne, Don Thiwanka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513929/
https://www.ncbi.nlm.nih.gov/pubmed/36163193
http://dx.doi.org/10.1186/s41927-022-00287-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513929/
https://www.ncbi.nlm.nih.gov/pubmed/36163193
http://dx.doi.org/10.1186/s41927-022-00287-7

Ejemplares similares